Tiny sensors with the power to detect cancer
Peer-Reviewed Publication
Updates every hour. Last Updated: 22-Jun-2026 00:15 ET (22-Jun-2026 04:15 GMT/UTC)
Researchers in the Netherlands examined blood thinner use and related events in people with cancer during this period using routine general practitioner (GP) records from 2018 to 2022. They analyzed data from 2,860 adults starting when the GP first registered palliative care and reviewed records until death or their last GP visit (median follow up period was about six weeks).
Researchers analyzed data from the U.S. Behavioral Risk Factor Surveillance System, a national telephone survey, to better understand how social isolation and physical isolation intersect with material deprivation, including financial strain and inadequate health care access. The study examined six preventive services: COVID-19, flu and pneumococcal vaccination, and breast, cervical, and colorectal cancer screenings.
Australian researchers have uncovered a critical mechanism driving the growth and spread of glioblastoma – one of the most aggressive and lethal forms of brain cancer – potentially paving the way for more effective treatments.
Researchers have uncovered a key cellular communication network that drives resistance to gemcitabine in pancreatic cancer. By integrating bulk, single-cell and spatial transcriptomics with experimental validation, the study identifies crosstalk between PRRX2-positive epithelial cells and SPP1-positive macrophages as a central mechanism promoting tumor aggressiveness and poor prognosis. The findings highlight new biomarkers and suggest potential combination treatment strategies to overcome chemotherapy resistance.
New research published by Wiley online in CANCER indicates that psychosocial factors—which influence how a person perceives, interprets, and reacts to their surroundings—do not affect an individual’s risk of developing cancer.